Business ❯ Pharmaceuticals

Biopharmaceuticals

Drug Development Product Development Neurology Biosimilars Research and Development Medical Devices Clinical Trials Merck KGaA Regulatory Affairs Therapeutics Anticoagulation Therapy Acquisitions

Bristol Myers Enters 2026 With Eliquis Medicaid Pact, Opdivo Qvantig Rollout, and Divergent Analyst Views

Analysts question the durability of cash flows as patent expirations approach.

Telix Faces Securities Class Action Over Prostate Cancer Disclosures and Supply Chain Claims

Telix Hit With Securities Class Action Over Prostate-Drug Claims and Supply Chain Assurances